Anna Pagano1, Barbara Tajima2, Joseph Guydish2. 1. Prevention Research Center, Pacific Institute for Research and Evaluation (PIRE), Oakland, CA, 94612. Electronic address: apagano@prev.org. 2. Institute for Health Policy Studies, University of California, San Francisco, San Francisco, CA, 94118.
Abstract
INTRODUCTION: Smoking rates among addiction treatment clients are 3-4 times higher than those of the general population. Recent studies indicate that ceasing tobacco use during treatment may improve recovery outcomes. Across the United States, publicly funded addiction treatment programs vary widely in terms of their tobacco policies and tobacco cessation services offered to clients. METHODS: The study reported here is the qualitative component of a larger study. Twenty-four programs were recruited from a random sample of publicly funded programs participating in the NIDA Clinical Trials Network. Semi-structured interviews were administered by phone to program directors. ATLAS.ti software was used to facilitate thematic analysis of interview transcripts. FINDINGS: While all directors expressed interest in helping clients to quit smoking, they cited numerous barriers to implementing tobacco policies and services. These included smoking culture, client resistance, lack of resources, staff smoking, and environmental barriers. Directors also cited several factors that they believed would support tobacco cessation. These included financial support, enhanced leadership, and state mandates against smoking in addiction treatment programs. CONCLUSION: Addiction treatment programs are beginning to place more emphasis on tobacco cessation during treatment. However, furthering this goal requires substantial infrastructural and cultural change. These qualitative study findings may help to inform Single State Agencies (SSAs) to support publicly funded addiction treatment programs in their tobacco cessation efforts. In order to maximize effectiveness, state-level policies regarding tobacco cessation during treatment should be informed by ongoing dialogue between service providers and SSAs.
INTRODUCTION: Smoking rates among addiction treatment clients are 3-4 times higher than those of the general population. Recent studies indicate that ceasing tobacco use during treatment may improve recovery outcomes. Across the United States, publicly funded addiction treatment programs vary widely in terms of their tobacco policies and tobacco cessation services offered to clients. METHODS: The study reported here is the qualitative component of a larger study. Twenty-four programs were recruited from a random sample of publicly funded programs participating in the NIDA Clinical Trials Network. Semi-structured interviews were administered by phone to program directors. ATLAS.ti software was used to facilitate thematic analysis of interview transcripts. FINDINGS: While all directors expressed interest in helping clients to quit smoking, they cited numerous barriers to implementing tobacco policies and services. These included smoking culture, client resistance, lack of resources, staff smoking, and environmental barriers. Directors also cited several factors that they believed would support tobacco cessation. These included financial support, enhanced leadership, and state mandates against smoking in addiction treatment programs. CONCLUSION: Addiction treatment programs are beginning to place more emphasis on tobacco cessation during treatment. However, furthering this goal requires substantial infrastructural and cultural change. These qualitative study findings may help to inform Single State Agencies (SSAs) to support publicly funded addiction treatment programs in their tobacco cessation efforts. In order to maximize effectiveness, state-level policies regarding tobacco cessation during treatment should be informed by ongoing dialogue between service providers and SSAs.
Authors: Bret E Fuller; Joseph Guydish; Janice Tsoh; Malcolm S Reid; Michael Resnick; Lucy Zammarelli; Douglas M Ziedonis; Clare Sears; Dennis McCarty Journal: J Subst Abuse Treat Date: 2006-09-26
Authors: Joseph Guydish; Deborah Yip; Thao Le; Noah R Gubner; Kevin Delucchi; Paul Roman Journal: Drug Alcohol Depend Date: 2017-08-01 Impact factor: 4.492
Authors: R Kathryn McHugh; Victoria R Votaw; Francesca Fulciniti; Hilary S Connery; Margaret L Griffin; Peter M Monti; Roger D Weiss Journal: J Subst Abuse Treat Date: 2016-12-30
Authors: Alana M Rojewski; Steffani R Bailey; Steven L Bernstein; Nina A Cooperman; Ellen R Gritz; Maher A Karam-Hage; Megan E Piper; Nancy A Rigotti; Graham W Warren Journal: Nicotine Tob Res Date: 2019-10-26 Impact factor: 4.244
Authors: Andrea H Weinberger; Misato Gbedemah; Melanie M Wall; Deborah S Hasin; Michael J Zvolensky; Renee D Goodwin Journal: Addiction Date: 2017-12-19 Impact factor: 6.526
Authors: Siwen Xie; Haruka Minami; Danusha Selva Kumar; Jacki Hecht; Erika Litvin Bloom; Christopher Kahler; Ana Abrantes; Lawrence H Price; Steven Ondersma; Richard A Brown Journal: J Subst Use Date: 2020-09-28